Connect with us

Crowdfunding

Exit for Bloovery Investors Who Had Closed Three Equity Crowdfunding Rounds

Bloovery is the leading digital wholesaler for the sale of flowers and plants and, in addition to allowing the florist to place orders online receiving them in store in just 24 hours, it is the first platform directly connected to Dutch flower auctions and thus allows for each order to receive an accurate assessment of the best available price.

Published

on

Italian startup Bloovery was acquired by Spanish scale-up Colvin, a leader in digitizing the floriculture market. Between 2017 and 2020, Bloovery had successfully closed three equity crowdfunding rounds, on Crowdfundme, Opstart, and Mamacrowd, respectively, raising a total of $275,000 (€265,000). In 2019, the startup had entered the accelerator program of VC LVenture, which, in the last round on Mamacrowd, had entered the capital.

Read more on the subject and find the most important business news of the day with the Born2invets mobile app.

Bloovery plans to become Europe’s first “flowertech”

Bloovery is the leading digital wholesaler for the sale of flowers and plants and, in addition to allowing the florist to place orders online receiving them in store in just 24 hours, it is the first platform directly connected to Dutch flower auctions and thus allows for each order to receive an accurate assessment of the best available price.

Colvin was founded in Barcelona in 2016 and has been present in Italy since 2018. Since its launch, it has raised about $72.6 million (€70 million) in funding, the latest in 2021 of $46.7 million (€45 million), and has also involved Italian investors, such as P101 sgr, Milano Investment Partners sgr, and Mediaset’s corporate venture capital.

Simone Guzzetti and Michele Dondi, co-founders of Bloovery, told StartupBusiness, “We are at the beginning of a long and wonderful journey. There is still so much to innovate in the industry. Together with Colvin, we are ready to create the world’s first flowertech company. We are very excited to join the Colvin family. By combining their international experience with Bloovery’s B2B expertise, we have a chance to make our mark in the flower industry.”

According to Radiocor reports, with the sale to Colvin, LVenture also exited its stake and the divestment of the entire stake generated a return on investment of about 2 times.

Recall that Bloovery’s last post-money valuation, after its third round, was 2.15 million while that of the previous two rounds had been 715,000 euros for Crowdfundme’s 31 investors and 94,000 euros for Opstart’s 19. So we assume that the exit generated satisfactory capital gains for these investors.

Tenth Exit for Crowdfundme

For Crowdfundme this is the tenth exit of one of the companies that have raised on the platform. Previous Exits include, for example, CleanBnB (a leading short-term rental company) and innovative-RFK (an industrial holding company that invests in startups and innovative SMEs), which are listed on the Milan Stock Exchange and Euronext Paris, respectively.

Tommaso Baldissera Pacchetti, CEO of CrowdFundMe, said, “We are very pleased with Bloovery’s Exit. This is another concrete case of our company’s dual mission: on the one hand to help innovative companies raise capital and grow, and on the other hand to enable investors to get a financial return. An issue that is now more important than ever, because with current levels of inflation, leaving money in the bank account results in a staggering erosion of its value. Equity Crowdfunding and CrowdFundMe have proven once again that they are key tools for profitable investing.”

__

(Featured image by AlbertoGuillen via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Crowdfunding buzz, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Anthony Donaghue writes about science and technology. Keeping abreast of the latest tech developments in various sectors, he has a keen interest on startups, especially inside and outside of Silicon Valley. From time to time, he also covers agritech and biotech, as well as consumer electronics, IT, AI, and fintech, among others. He has also written about IPOs, cannabis, and investing.